Capricor Therapeutics (CAPR)
(Delayed Data from NSDQ)
$18.86 USD
+0.37 (2.00%)
Updated Oct 18, 2024 04:00 PM ET
After-Market: $18.84 -0.02 (-0.11%) 7:20 PM ET
2-Buy of 5 2
F Value F Growth C Momentum F VGM
Capricor Therapeutics (CAPR) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$41.80 | $77.00 | $25.00 | 126.07% |
Price Target
Based on short-term price targets offered by five analysts, the average price target for Capricor Therapeutics comes to $41.80. The forecasts range from a low of $25.00 to a high of $77.00. The average price target represents an increase of 126.07% from the last closing price of $18.49.
Analyst Price Targets (5 )
Broker Rating
Capricor Therapeutics currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by five brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on five recommendations.
Of the five recommendations deriving the current ABR, five are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 5 | 5 | 5 | 5 | 5 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
10/9/2024 | H.C. Wainwright & Co. | Joseph Pantginis | Strong Buy | Strong Buy |
9/20/2024 | Cantor Fitzgerald & Co | Kristen Kluska | Strong Buy | Strong Buy |
9/18/2024 | LadenburgThalmann | Aydin Huseynov | Strong Buy | Strong Buy |
9/17/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/23/2024 | Maxim Group | Jason Mccarthy | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 5 |
Average Target Price | $41.80 |
LT Growth Rate | NA |
Industry | Medical - Products |
Industry Rank by ABR | 71 of 252 |
Current Quarter EPS Est: | -0.34 |
CAPR FAQs
Capricor Therapeutics, Inc. (CAPR) currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 5 brokerage firms.
The average price target for Capricor Therapeutics, Inc. (CAPR) is $41.80. The current on short-term price targets is based on 4 reports.
The forecasts for Capricor Therapeutics, Inc. (CAPR) range from a low of $25 to a high of $77. The average price target represents a increase of $126.07 from the last closing price of $18.49.
The current UPSIDE for Capricor Therapeutics, Inc. (CAPR) is 126.07%
Based on short-term price targets offered by five analysts, the average price target for Capricor Therapeutics comes to $41.80. The forecasts range from a low of $25.00 to a high of $77.00. The average price target represents an increase of 126.07% from the last closing price of $18.49.